Rigel Pharmaceuticals Inc (RIGL)
Working Capital Ratio
17.31%
Quarterly · Period ending:
RIGL Working Capital Ratio
Latest reported17.31%period ending
Latest reported17.31%period ending
RIGL Quarterly Working Capital Ratio (72.56% → 17.31%)
Quarterly working capital ratio
High-resolution chart · PNG
RIGL working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 17.3051% | |
| 28.643% | |
| 27.4398% | |
| 49.6949% | |
| 42.9325% | |
| 45.4243% | |
| 43.7893% | |
| 37.4088% | |
| 28.0933% | |
| 15.2451% | |
| 39.2399% | |
| 40.5388% | |
| 48.5964% | |
| 49.7152% | |
| 37.7512% | |
| 54.6454% | |
| 51.223% | |
| 53.4721% | |
| 54.3322% | |
| 59.9524% | |
| 61.833% | |
| 67.0096% | |
| 43.6156% | |
| 53.3537% | |
| 56.7465% | |
| 59.4017% | |
| 41.1963% | |
| 60.8711% | |
| 61.5556% | |
| 65.5043% | |
| 78.5377% | |
| 82.2772% | |
| 86.1725% | |
| 78.7649% | |
| 83.1963% | |
| 76.5684% | |
| 79.4579% | |
| 81.2023% | |
| 68.6334% | |
| 74.3618% | |
| 75.4088% | |
| 71.9385% | |
| 72.281% | |
| 72.8189% | |
| 75.0561% | |
| 77.3576% | |
| 88.5665% | |
| 91.1303% | |
| 91.8018% | |
| 93.4443% | |
| 92.7996% | |
| 93.8101% | |
| 94.0498% | |
| 94.1005% | |
| 93.6173% | |
| 90.5968% | |
| 91.8422% | |
| 93.2132% | |
| 92.8434% | |
| 94.3106% | |
| 94.7966% | |
| 91.3816% | |
| 90.3077% | |
| 90.4335% | |
| 65.2386% | |
| 44.7365% | |
| 83.9787% | |
| 84.5029% | |
| 71.4689% | |
| 77.4358% | |
| 79.2003% | |
| 83.6739% | |
| 88.9721% | |
| 92.507% | |
| 82.0613% | |
| 89.0595% | |
| 90.6956% | |
| 85.4608% | |
| 85.461% | |
| 86.9844% | |
| 86.5147% | |
| 81.763% | |
| 80.5516% | |
| 85.6924% | |
| 70.7285% | |
| 75.6478% | |
| 79.6998% | |
| 84.4282% | |
| 86.4904% | |
| 87.8887% | |
| 75.7492% | |
| 77.354% | |
| 76.314% | |
| 46.6397% | |
| 50.7262% | |
| 42.5257% | |
| 57.1469% | |
| 64.7231% | |
| 56.7753% | |
| 61.1272% |